ArticleThe Pan African medical journal2025
Assessment of maternal and neonatal outcomes in pregnant women with and without gestational diabetes mellitus diagnosed at the three trimesters of pregnancy: a cross-sectional study in a hospital in Northeast Mexico.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: gestational diabetes mellitus is a common complication of pregnancy. Diagnostic tests should be performed between 24-28 weeks of pregnancy; however, studies have shown that early or late screening could provide certain benefits in pregnancy outcomes. The study aimed to determine the impact of performing early or late screening tests for GDM in maternal and neonatal outcomes compared to the standard screening time. Methods: we conducted a cross-sectional study including adult pregnant women with a high risk of GDM. Baseline characteristics, risk factors and differences in maternal and neonatal outcomes were evaluated (e.g. preeclampsia, infections, birth weight, etc.). Multivariable logistic regression analysis was performed to identify factors associated with adverse maternal outcomes and adverse neonatal outcomes. Results: a total of 803 patients were included, mean gestational age at the end of pregnancy was 37.6+4.4 weeks. 232/803 patients (28.9%) underwent screening in the standard time. A total of 79/232 (34.0%) from those that underwent screening at the standard time were diagnosed with GDM, and 102/286 (35.6%) and 111/285 (38.9%) were diagnosed in the early and late screening times, respectively. Age >30, BMI ≥25, and family history of DM were found as significant risk factors for gestational diabetes mellitus in the multivariable logistic regression analyses. Earlier gestational age, and caesarean section were significantly more frequent in women with GDM compared with women without GDM. No significant differences were found in the neonatal outcomes. Conclusion: our results suggest a similar proportion of patients are diagnosed with GDM when comparing the three screening times and that early or late screening times do not provide any additional benefits on neonatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.